We are live on ! Find out more
PTX

Pernix Therapeutics Holdings, Inc.
PTX

Delisted

PTX was delisted on the 4th of March, 2019.

32 hedge funds and large institutions have $6.09M invested in Pernix Therapeutics Holdings, Inc. in 2017 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

264% more call options, than puts

Call options by funds: $382K | Put options by funds: $105K

75% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 4

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

7% more funds holding

Funds holding: 3032 (+2)

23% less capital invested

Capital invested by funds: $7.93M → $6.09M (-$1.84M)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.8%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
7
Increased
7
Reduced
5
Closed
4
Calls
$382K
Puts
$105K
Net Calls
+$277K
Net Calls Change
+$373K
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.58M +$60.6K +18,900 +2%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.03M -$241K -75,033 -19%
AC
3
Aisling Capital
New York
$662K
BlackRock
4
BlackRock
New York
$651K +$4.9K +1,528 +0.7%
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$261K +$146K +45,358 +121%
Jacobs Levy Equity Management
6
Jacobs Levy Equity Management
New Jersey
$194K +$71.9K +22,421 +57%
Cetera Investment Advisers
7
Cetera Investment Advisers
Illinois
$147K
Geode Capital Management
8
Geode Capital Management
Massachusetts
$125K
Bank of New York Mellon
9
Bank of New York Mellon
New York
$77K +$99 +31 +0.1%
Morgan Stanley
10
Morgan Stanley
New York
$69K -$15.8K -4,924 -18%
SC
11
Searle & Co
Connecticut
$54K
Goldman Sachs
12
Goldman Sachs
New York
$49K +$50.3K +15,661 New
Northern Trust
13
Northern Trust
Illinois
$44K
Susquehanna International Group
14
Susquehanna International Group
Pennsylvania
$41K +$42K +13,096 New
Group One Trading
15
Group One Trading
Illinois
$41K +$42.1K +13,120 New
DTL
16
Dynamic Technology Lab
Singapore
$37K +$38.3K +11,937 New
UBS Group
17
UBS Group
Switzerland
$8K +$4.8K +1,496 +131%
FDCDDQ
18
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.15K
Simplex Trading
19
Simplex Trading
Illinois
$3K -$16.8K -5,240 -81%
CCM
20
Covington Capital Management
California
$3K +$3.21K +1,000 New
SAMH
21
Shanda Asset Management Holdings
British Virgin Islands
$3K +$3.21K +1,000 New
AG
22
Advisor Group
Arizona
$1K -$2.57K -800 -82%
IA
23
IFP Advisors
Florida
$1K
Wells Fargo
24
Wells Fargo
California
$1K
D.E. Shaw & Co
25
D.E. Shaw & Co
New York
-$51K -12,609 Closed

PTX Hedge Fund Activity: Q3 2017 in Review

32 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Pernix Therapeutics Holdings, Inc. (PTX) for Q3 2017, worth a combined $6.09M — down 23% from $7.93M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new PTX positions and 4 closed out — a net gain of 3 holders — while 7 added to existing stakes and 5 trimmed.

The largest buyer was California Public Employees Retirement System, adding an estimated $146K. The largest seller was Vanguard Group, cutting an estimated $241K.

  • 32 institutional investors held Pernix Therapeutics Holdings, Inc. (PTX) as of Q3 2017, up from 30 in Q2 2017.
  • Funds reported $6.09M of Pernix Therapeutics Holdings, Inc. stock for Q3 2017, down 23% quarter-over-quarter.
  • 7 funds opened new Pernix Therapeutics Holdings, Inc. positions in Q3 2017 and 4 closed out, a net change of +3 holders.
  • The largest Pernix Therapeutics Holdings, Inc. buyer in Q3 2017 was California Public Employees Retirement System, an estimated $146K added.
  • The largest Pernix Therapeutics Holdings, Inc. seller in Q3 2017 was Vanguard Group, an estimated $241K sold.

Based on aggregated 13F filings for Q3 2017.